31 Interstitial Cystitis Clinical Trials in Pittsburgh, PA (2026)

Q: How do I join a clinical trial in Pittsburgh?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Pittsburgh research site will contact you.

Recruiting Interstitial Cystitis Studies in Pittsburgh

NCT03494075Recruiting

MyPaTH Story Booth

The MyPaTH Story Booth will use an (audio) "document" approach to elicit in depth experiential knowledge or perspectives from patients and caregivers by recording their personal stories....

Pittsburgh, PA2,000 participantsUniversity of Pittsburgh

View Study Details

NCT02890342Recruiting

Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia

Background: People s bodies need to break down food into the chemicals. These chemicals are used for energy and growth. Some people cannot process all chemicals very well. Too much of some chemicals ...

Pittsburgh, PA1,045 participantsNational Human Genome Research Institute (NHGRI)

View Study Details

NCT01241305Recruiting

One-Time DNA Study for Vasculitis

The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of these studies will pro...

Pittsburgh, PA1,000 participantsUniversity of Pennsylvania

View Study Details

NCT05748730Recruiting

Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention

This protocol will test the effectiveness of an intervention, iCHART (integrated Care to Help At-Risk Teens) and facilitate recruitment for other studies in the larger ETUDES Center grant, which are f...

Pittsburgh, PANA900 participantsUniversity of Pittsburgh

View Study Details

NCT00373841Recruiting

Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)

The purpose of the study is to identify genetic and biologic markers that may predict the loss of lung function due to idiopathic pulmonary fibrosis. The studies will compare genetic and biologic mark...

Pittsburgh, PA500 participantsUniversity of Pittsburgh

View Study Details

NCT06029348Recruiting

Cerebrovascular Health and Resilience in Midlife

This study examines cardiovascular responses to a brief psychological challenge under laboratory conditions among adult volunteers. The study volunteers are asked to complete two study sessions. In on...

Pittsburgh, PANA450 participantsUniversity of Pittsburgh

View Study Details

NCT05049057Recruiting

Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI

This study aims to assess the effect and safety of erenumab compared to placebo for the treatment of acute posttraumatic headache (PTH) in military service members and civilians with mild traumatic br...

Pittsburgh, PAPHASE2404 participantsHenry M. Jackson Foundation for the Advancement of Military Medicine

View Study Details

NCT06863272Recruiting

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

The purpose of this substudy is to assess the efficacy and safety of ifinatamab deruxtecan (I-DXd), given alone or with other treatments in participants with metastatic castration-resistant prostate c...

Pittsburgh, PAPHASE1360 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06370182Recruiting

Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter

The objective of this study is to assess the safety and effectiveness of mechanical thrombectomy (MT) using the ANA funnel catheter in its intended use, which is to facilitate the navigation and deplo...

Pittsburgh, PANA327 participantsAnaconda Biomed S.L.

View Study Details

NCT06339177Recruiting

Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study

Background: Hemophagocytic lymphohistiocytosis (HLH) is a disease caused by disrupted immune function. People with HLH are prone to fevers and illnesses, which can be fatal. Some people develop a gen...

Pittsburgh, PA300 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT07312734Recruiting

Study to Enable New Diagnostics for Pulmonary Microbes in People With CF

Sputum culture has been the best approach to detect harmful bacteria in the lungs of people with cystic fibrosis (CF). With the widespread use of new CF therapies (like Trikafta and Alyftrak), it is m...

Pittsburgh, PA300 participantsChris Goss

View Study Details

NCT07335497Recruiting

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

The purpose of this study is to determine the safety and tolerability of monotherapy CR-001 and identify the maximum tolerated dose (MTD), and/or optimal biologic dose and Recommended Phase 2 Dose(s) ...

Pittsburgh, PAPHASE1290 participantsCrescent Biopharma, Inc.

View Study Details

NCT07214311Recruiting

Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty

The goal of this clinical trial is to evaluate whether the investigational drug PLG0206 can help reduce recurrence of infection in adults who have undergone total knee replacement and are receiving a ...

Pittsburgh, PAPHASE2240 participantsPeptilogics

View Study Details

NCT07141706Recruiting

A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

This is a multicenter, open-label, multiple-dose, FIH Phase 1a/1b study. Phase 1a adopts an accelerated titration design and a BOIN design to identify the MTD or MAD of DB-1317; Phase 1b includes up t...

Pittsburgh, PAPHASE1233 participantsDualityBio Inc.

View Study Details

NCT06833853Recruiting

A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients

The purpose of this research is to learn if the CellSearch Circulating Tumor Cells (CTC) test can help doctors in making decisions about treatment and monitoring of breast cancer. The test consists of...

Pittsburgh, PA187 participantsMenarini Silicon Biosystems, INC

View Study Details

NCT05541029Recruiting

Music Listening: A Mechanistic Trial

A randomized within-subject crossover trial to compare the effects of live and recorded music listening on biomarkers of stress and pain among children receiving mechanical ventilation in the pediatri...

Pittsburgh, PANA171 participantsUniversity of Pittsburgh

View Study Details

NCT06191484Recruiting

Risk and Resilience to Suicide Following Late-Life Spousal Bereavement

The purpose of the RISE study is to examine how the 24-hour rhythm of sleep and social activity relate to mood and suicidal ideation among older adults that recently lost a spouse or life partner....

Pittsburgh, PANA169 participantsUniversity of Pittsburgh

View Study Details

NCT03056794Recruiting

Natural History and Advanced Genetic Study of Pyruvate Dehydrogenase Complex Deficiencies

Children and adults with pyruvate dehydrogenase complex deficiency (PDCD) are participating in a research study seeking to better understand the genetic causes, symptoms, usefulness of current treatme...

Pittsburgh, PA150 participantsUniversity of Pittsburgh

View Study Details

NCT04996628Recruiting

Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis

Abdominal pain in chronic pancreatitis (CP) affects up to 90% of patients during the course of their disease, and response to currently available therapies is suboptimal and unpredictable. The propose...

Pittsburgh, PANA150 participantsUniversity of Pittsburgh

View Study Details

NCT06710756Recruiting

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Phase I/IIa image-guided, alpha-particle therapy study of \[203Pb\]Pb-PSV359 and \[212Pb\]Pb-PSV359 in patients with solid tumors that are known to be Fibroblast Activation Protein (FAP)-positive....

Pittsburgh, PAPHASE1112 participantsPerspective Therapeutics

View Study Details

NCT07423078Recruiting

Window of Opportunity in Preserving Laryngeal Function Trial

This trial will study the safety and tolerability and disease survival rates in adult patients with recurrent/metastatic (R/M) HNSCC when treated with carboplatin or cisplatin, paclitaxel, and toripal...

Pittsburgh, PAPHASE287 participantsMatthew Spector

View Study Details

NCT07133139Recruiting

Treatment Validation for Myofascial Pain

The goal of this clinical trial is to see if a body test called the NUN biomarker can track changes in chronic low back pain after dry needling and predict who will feel better. This study is for adul...

Pittsburgh, PANA80 participantsAjay Wasan, MD, Msc

View Study Details

NCT07654205Recruiting

Smartphone-based Intervention for Young Adults With ADHD

The primary goal of this clinical trial is to test if a smartphone-based intervention is feasible \& acceptable among young adults with ADHD who also engage in risky drinking behaviors. A secondary ai...

Pittsburgh, PANA70 participantsTraci Kennedy

View Study Details

NCT07124078Recruiting

A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

This study will be conducted to compare Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy....

Pittsburgh, PAPHASE260 participantsIncyte Corporation

View Study Details

NCT05283330Recruiting

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

A Phase 1 Open-Label, First-in-human, Dose Escalation and Expansion Study to Determine the Safety, Tolerability, Dosimetry, Pharmacokinetics, and Preliminary Efficacy of 212Pb-DOTAM-GRPR1 in Adult Par...

Pittsburgh, PAPHASE148 participantsOrano Med Theranostics, SAS

View Study Details

NCT07493512Recruiting

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

The primary objective of this trial is to determine the safety profile of xaluritamig at the proposed regimen in adult participants with metastatic castration-resistant prostate cancer (mCRPC)....

Pittsburgh, PAPHASE140 participantsAmgen

View Study Details

NCT06654037Recruiting

Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer

This phase I trial tests the safety, side effects, and best dose of abemaciclib in combination with 5-fluorouracil and how well it works in treating patients with colorectal cancer that has spread fro...

Pittsburgh, PAPHASE139 participantsNational Cancer Institute (NCI)

View Study Details

NCT05398120Recruiting

Skills Group for Youth at Clinical High-Risk for Psychosis

This study is intended to test the feasibility of an integrated cognitive behavioral therapy (CBT) and dialectical behavioral therapy (DBT) skills group for adolescents and young adults at clinical hi...

Pittsburgh, PANA30 participantsUniversity of Pittsburgh

View Study Details

NCT07121010Recruiting

How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses

The goal of this clinical trial is to learn how different protein types affect the body's metabolism and immune system in healthy adults. The main questions it aims to answer are: Does drinking smoot...

Pittsburgh, PANA20 participantsUniversity of Pittsburgh

View Study Details

NCT04925492Recruiting

PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD

The purpose of this study is to find objective biomarkers of vaso-occlusion (blood vessel blockage) in people with SCD. Using information from earlier studies and work being done, researchers have dev...

Pittsburgh, PAPHASE120 participantsEnrico Novelli

View Study Details

NCT06052839Recruiting

Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC

The rationale for the new sequence of pulsed dose chemotherapy proposed in this trial is based on the hypotheses that current standard dosing of chemotherapy plus pembrolizumab ultimately suppresses t...

Pittsburgh, PAPHASE215 participantsDan Zandberg

View Study Details

About Interstitial Cystitis Clinical Trials in Pittsburgh

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 31 interstitial cystitis clinical trials recruiting participants in Pittsburgh, PA. These studies are seeking a combined 9,797 participants. Research is being sponsored by University of Pittsburgh, National Human Genome Research Institute (NHGRI), University of Pennsylvania and 19 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Pittsburgh — FAQ

Are there interstitial cystitis clinical trials in Pittsburgh?

Yes, there are 31 interstitial cystitis clinical trials currently recruiting in Pittsburgh, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Pittsburgh?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pittsburgh research site will contact you about next steps.

Are clinical trials in Pittsburgh free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pittsburgh studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 31 active trials in Pittsburgh are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated July 17, 2026 from ClinicalTrials.gov